Humanwell Healthcare (Group) Co.,Ltd.

Shanghai Stock Exchange 600079.SS

Humanwell Healthcare (Group) Co.,Ltd. EBITDA Margin for the year ending December 31, 2023: 18.59%

Humanwell Healthcare (Group) Co.,Ltd. EBITDA Margin is 18.59% for the year ending December 31, 2023, a -11.10% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Humanwell Healthcare (Group) Co.,Ltd. EBITDA Margin for the year ending December 31, 2022 was 20.91%, a 24.38% change year over year.
Humanwell Healthcare (Group) Co.,Ltd. EBITDA Margin for the year ending December 31, 2021 was 16.81%, a -0.48% change year over year.
Humanwell Healthcare (Group) Co.,Ltd. EBITDA Margin for the year ending December 31, 2020 was 16.89%, a 16.65% change year over year.
Humanwell Healthcare (Group) Co.,Ltd. EBITDA Margin for the year ending December 31, 2019 was 14.48%, a 2,115.22% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Shanghai Stock Exchange: 600079.SS

Humanwell Healthcare (Group) Co.,Ltd.

CEO	Mr. Xiafei Deng
IPO Date	June 6, 1997
Location	China
Headquarters	No.666 Gaoxin Road
Employees	17,676
Sector	Health Care
Industries Pharmaceuticals Hospitals & Clinics

Description

Humanwell Healthcare (Group) Co.,Ltd. provides healthcare solutions in the Asia Pacific, North America, Africa, and internationally. The company offers anesthetic/analgesic products; women's health products for unplanned pregnancy, emergency contraception, and birth control; consumer healthcare products for women; and CNS drugs for bronchitis, migraine, dysmenorrhea, neuralgia, epilepsy, acute and chronic cerebrovascular diseases, and brain injury and peripheral vascular diseases. It also provides herbal medicines for cold and flu, rheumatoid arthritis, skin care, hepatitis, urinary tract infection, and hypomnesis; anti-infection drugs; OTC medicines for digestive disorders, cold and flu, anti-inflammation, anti-infection, and nutritional supplements; and other products targeting cardiovascular, gastrointestinal, and reproductive diseases. The company was formerly known as Wuhan Humanwell Healthcare (Group) Co., Ltd. and changed its name to Humanwell Healthcare (Group) Co.,Ltd. in March 2013. Humanwell Healthcare (Group) Co.,Ltd. was founded in 1993 and is based in Wuhan, China.

Key trends

Past 5 years